BioCardia, Inc.
BCDA
$1.96
-$0.145-6.91%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 31.33% | 38.36% | 34.21% | 14.45% | 2.82% |
| Total Depreciation and Amortization | -20.24% | -15.29% | -17.20% | -7.95% | 2.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.69% | -25.98% | -20.82% | -8.79% | -6.36% |
| Change in Net Operating Assets | -1,043.41% | -435.77% | -70.60% | -101.75% | 160.28% |
| Cash from Operations | 19.53% | 34.32% | 33.68% | 12.38% | 5.56% |
| Capital Expenditure | 50.00% | 64.29% | 89.29% | 96.08% | 82.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 50.00% | 64.29% | 89.29% | 96.08% | 82.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 140.47% | 71.27% | -31.82% | -3.01% | -20.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -89.12% | -133.92% | 1.67% | 4.35% | -58.37% |
| Cash from Financing | 149.60% | 65.09% | -34.34% | -2.85% | -27.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 120.26% | 164.05% | 33.07% | 22.96% | -13.63% |
